Markers of endothelial damage in patients with chronic kidney disease on hemodialysis
Data de publicació2017-04-01
Agüera, Maria L.
Arriba, Gabriel de
Peso, Gloria del
Portolés, José M.
MetadadesMostra el registre d'unitat complet
Patients with Stage 5 chronic kidney disease who are on hemodialysis (HD) remain in a chronic inflammatory state, characterized by the accumulation of uremic toxins that induce endothelial damage and cardiovascular disease (CVD). Our aim was to examine microvesicles (MVs), monocyte subpopulations, and angiopoietins (Ang) to identify prognostic markers in HD patients with or without diabetes mellitus (DM). A total of 160 prevalent HD patients from 10 centers across Spain were obtained from the Biobank of the Nephrology Renal Network (Madrid, Spain): 80 patients with DM and 80 patients without DM who were matched for clinical and demographic criteria. MVs from plasma and several monocyte subpopulations (CD142+/CD16+, CD14+/CD162+) were analyzed by flow cytometry, and the plasma concentrations of Ang1 and Ang2 were quantified by ELISA. Data on CVD were gathered over the 5.5 yr after these samples were obtained. MV level, monocyte subpopulations (CD14+/CD162+ and CD142+/CD16+), and Ang2-to-Ang1 ratios increased in HD patients with DM compared with non-DM patients. Moreover, MV level above the median (264 MVs/µl) was associated independently with greater mortality. MVs, monocyte subpopulations, and Ang2-to-Ang1 ratio can be used as predictors for CVD. In addition, MV level has a potential predictive value in the prevention of CVD in HD patients. These parameters undergo more extensive changes in patients with DM.
És part deAmerican Journal of Physiology-Renal Physiology, 2017, vol. 312, núm. 4, p. 673-681
Projectes de recerca europeus
Mostrant elements relacionats per títol, autor i matèria.
Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: The NEFRONA project Junyent, Mireia; Martínez Alonso, Montserrat; Borràs, Mercè; Betriu i Bars, M. Àngels; Coll, Blai; Craver Hospital, Lourdes; Marco Mayayo, M. Paz; Sarró, Felipe; Valdivielso Revilla, José Manuel; Fernández i Giráldez, Elvira (Sociedad Española de Nefrologia, 2010)Background: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). Cardiovascular risk assessment in this population is hampered by the failure of ...
The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem Ortiz, Alberto; Sanchez-Niño, Maria-Dolores; Crespo-Barrio, Marta; De-Sequera-Ortiz, Patricia; Fernández i Giráldez, Elvira; García-Maset, Rafael; Macía-Heras, Manuel; Pérez Fontán, Miguel; Rodríguez, Mariano; Salgueira-Lazo, Mercedes; Sánchez Alvarez, Emilio; Santamaría-Olmo, Rafael; Simal-Blanco, Fernando; Pino, María Dolores del (Elsevier, 2019)The Global Burden of Disease (GBD) study measures the health of populations worldwide and by country on an annual basis and aims at helping guide public policy on health issues. The GBD estimates for Spain in 2016 and ...
The active form of vitamin D, calcitriol, induces a complex dual upregulation of endothelin and nitric oxide in cultured endothelial cells Martínez-Miguel, Patricia; Valdivielso Revilla, José Manuel; Medrano-Andrés, Diana; Román-García, Pablo; Cano-Peñalver, Jose Luis; Rodríguez-Puyol, Manuel; Rodríguez-Puyol, Diego; López-Ongil, Susana (American Physiological Society, 2014)Despite the presence of vitamin D receptor (VDR) in endothelial cells, the effect of vitamin D on endothelial function is unknown. An unbalanced production of vasoactive endothelial factors such as nitric oxide (NO) or ...